What is Meptin (Meperidine) 25mg used for?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Meptin 25mg Used For?

Meptin (Meperidine) 25mg is a synthetic opioid analgesic used for moderate to severe acute pain, but it should be considered a second-line agent due to significant safety concerns and availability of superior alternatives. 1, 2

Primary Indication

  • Meperidine is FDA-approved for relieving moderate to severe pain, typically administered intramuscularly or intravenously due to poor oral bioavailability. 3, 4
  • The 25mg dose represents a lower-end dosing option, often used in combination with other sedatives or in patients requiring dose reduction (elderly, debilitated patients). 1
  • Analgesic effects typically last 3-4 hours with parenteral administration, with onset of action within 1-2 minutes when given intravenously. 1, 3

Clinical Context and Limitations

Why Meperidine is NOT Recommended as First-Line

Current guidelines explicitly recommend against using meperidine for cancer pain and chronic pain management. 1 The evidence is clear:

  • The NCCN guidelines state that "meperidine and propoxyphene are contraindicated for chronic pain" due to accumulation of renally cleared metabolites that can result in neurotoxicity. 1
  • Meperidine has no place as a WHO level 3 opioid since other opioids have become available. 1
  • Morphine, hydromorphone, oxycodone, or fentanyl provide more reliable analgesia with better safety profiles and should be used instead. 2, 5

Critical Safety Concerns

Meperidine is absolutely contraindicated in several high-risk situations:

  • Patients with renal insufficiency (GFR <30 mL/min/1.73 m²) and end-stage renal disease due to accumulation of normeperidine, an active metabolite that causes seizures and CNS toxicity. 2, 5
  • Patients taking monoamine oxidase inhibitors (MAOIs) due to risk of fatal serotonergic reactions; must avoid use within 14-15 days of MAOI therapy. 5, 3
  • Patients with dehydration or impaired renal function are at increased risk for neurotoxicity from normeperidine accumulation. 1

Serotonergic Effects

  • Meperidine has serotonergic effects that increase the likelihood of toxicity when combined with other medications that increase serotonergic activity. 2, 6
  • Monitor for signs of serotonin syndrome including mental status changes, neuromuscular hyperactivity (tremors, clonus, hyperreflexia), and autonomic instability (hypertension, tachycardia, hyperthermia). 6, 5

Limited Appropriate Uses

Acute Pain Management (Short-Term Only)

  • In emergency settings, meperidine 25mg IM may be used for acute abdominal pain when administered for less than 48 hours, though it does not provide superior analgesia compared to alternatives. 7
  • Studies show meperidine reduces pain intensity without significantly interfering with clinical diagnosis in acute abdominal pain (diagnostic accuracy 96%). 7

Procedural Sedation

  • During endoscopic procedures, meperidine may be combined with benzodiazepines (typically midazolam or diazepam) for sedation and analgesia. 1
  • The combination has synergistic effects on respiratory depression, requiring careful monitoring and availability of naloxone for reversal. 1

Shivering Control

  • Meperidine has unique antishivering properties mediated through kappa-opioid receptors, making it more effective than equianalgesic doses of morphine for treating postoperative or hypothermia-induced shivering. 8
  • This represents one of the few clinical scenarios where meperidine may have advantages over other opioids. 8

Common Pitfalls to Avoid

  • Never use meperidine for chronic pain management - the risk of normeperidine accumulation and neurotoxicity (myoclonus, seizures) increases with repeated dosing. 1, 3
  • Do not assume meperidine is superior for biliary or renal colic - clinical evidence shows no advantage over other opioids for these conditions despite historical teaching. 4, 9
  • Avoid rapid IV administration - this increases risk of hypotension and requires slower infusion rates. 5
  • Do not use in pregnancy or lactation per standard opioid precautions. 5

Monitoring Requirements

  • Oxygen saturation monitoring is essential due to respiratory depression risk, especially when combined with benzodiazepines or other CNS depressants. 5
  • Naloxone should be immediately available for reversal of respiratory depression. 1, 5
  • Observe for at least 2 hours after naloxone administration to ensure resedation does not occur. 1

Preferred Alternatives

For moderate to severe pain requiring opioid therapy, use instead:

  • Morphine 5-15 mg oral or 2-5 mg IV for opioid-naive patients (standard first-line). 1
  • Hydromorphone, oxycodone, or fentanyl for patients with specific contraindications to morphine. 1, 2
  • For renal impairment specifically: fentanyl, sufentanil, or methadone (under experienced supervision) as they have no active metabolites. 2, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Disadvantages of Demerol (Meperidine) for Pain Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Meperidine: therapeutic use and toxicity.

The Journal of emergency medicine, 1995

Research

Removing meperidine from the health-system formulary--frequently asked questions.

Journal of pain & palliative care pharmacotherapy, 2002

Guideline

Pethidine Precautions and Contraindications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Risks of Serotonin Syndrome with Remifentanil and Rasagiline

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Naloxone, meperidine, and shivering.

Anesthesiology, 1993

Research

Meperidine: a critical review.

American journal of therapeutics, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.